CCR2 and cancer: Studies have demonstrated that in CCR2-DTR mice with pre-metastatic lungs, the inhibition of inflammatory monocyte recruitment through the CCL2-CCR2 axis resulted in a significant reduction in the expression of MMP9 and the extravasation of cancer cells.